Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
68Ga-FAPI-04 PET/CT in Fibrotic Disease
NCT04831034Phase 1Unknown
- Sponsor
- The First Hospital of Fujian Medical University
- Start
- Apr 2021
- Primary completion
- Apr 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of 68Ga-FAPI-4 in fibrosis, sponsored by The First Hospital of Fujian Medical University. Primary endpoint: Standardized Uptake Value at 30 days. Status: unknown.
02
Drugs
68Ga-FAPI-4
03
Conditions
fibrosis
Beyond the preview
Go deeper on NCT04831034.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04831034.